MedBen Rx
  • About Us
  • Genomic Testing
  • Resources
    • MedBen Rx Blog
    • Online Services & Forms
  • Contact Us
  • MedBen Access
  • MedBen.com
Select Page

PBMs’ Egregious Pricing Methodology Remains Untamed, but MedBen Rx Advocate Has the Solution

Jun 14, 2019 | MedBen Rx Advocate, Pharmacy Benefits Manager (PBM), Transparency

A recent article in the Columbus Dispatch highlights how pharmacy benefits managers (PBMs) are making big profits on the backs of the taxpayers and threatening the existence of the independent pharmacy. The article focuses on the Ohio Medicaid program, but this issue...

With MedBen Rx, Employers Pay Only What’s Necessary

Jun 4, 2019 | MedBen Rx, Transparency

The MedBen Rx approach to drug pricing is straightforward. We keep client costs low by reimbursing pharmacies what they pay for prescription drugs, plus a reasonable dispensing fee. By doing so, we ensure that self-funded employers get the maximum value from their...

Rx Spending Hikes Call for Smart Solutions

Mar 25, 2019 | Average Wholesale Price, MedBen Rx, Pharmacies, Pharmacy Benefits Manager (PBM), Rebates, Rx Costs, Rx Spending, Transparency

In just four years, U.S. retail prescription drug spending grew nearly 27%… a substantial increase that illustrates the need for pharmacy solutions like those available through MedBen Rx. A new report from the Pew Charitable Trusts found that annual spending on...

All MedBen Clients Can Benefit from Rx Solutions

Mar 12, 2019 | MedBen Rx, MedBen Rx Advocate, MedBen Rx Alliance, Rebates, Rx Costs, Transparency

MedBen Rx offers employers a better way to provide and manage prescription benefits, regardless of their size or industry type. Our pharmacy solutions counter inflated prescription list prices with common-sense reimbursement methods. Self-funded employers can take...

MedBen Rx Solutions Put Transparency Up Front

Oct 23, 2018 | Legislation, MedBen Access, MedBen Rx, Online Services, Rebates, Rx Costs, Transparency

In an effort to improve drug pricing transparency, the Department of Health and Human Services recently released a proposal requiring drug companies to include their list prices in consumer ads. But MedBen already provides far more transparent Rx solutions. Drug...

MedBen Rx: Lessons in Savings and Transparency

Aug 24, 2018 | MedBen Rx, MedBen Rx Advocate, MedBen Rx Alliance, Rx Costs, Savings, Transparency

A recent Forbes.com headline refers to U.S. prescription drug pricing practices as “Lessons in Obfuscation.” Unlike most products that have clearly defined prices, prescription drugs start with an acquisition cost paid by the pharmacy, which it then...
« Older Entries
Next Entries »

Categories

  • 340B
  • Access solution
  • Access solutions
  • Acquisition Cost Index (ACI)
  • Affordable Care Act
  • Anniversaries
  • Announcements
  • Appropriateness Solutions
  • Avande
  • Average Wholesale Price
  • Benefits Advisory Conference
  • Benefits preservation
  • Biologics
  • Biosimilar
  • Brand Name Drugs
  • Brian Fargus
  • Cancer
  • Caroline Fraker
  • Case Study
  • Cholesterol
  • Claims
  • Client Report
  • Comparative Effectiveness
  • Compliance
  • Consolidated Appropriations Act of 2021 (CAA)
  • Cost Plus
  • Cost Plus Pricing
  • Cost projections
  • Cost Savings
  • Diabetes
  • Discounts
  • Doug Freeman
  • Drug costs
  • Drug makers
  • Drug marketing
  • Drug reimportation
  • Evidence-based research
  • Federal Trade Commission (FTC)
  • Food and Drug Administration (FDA)
  • Formularies
  • Fraud
  • Gene therapy
  • Generic Drugs
  • Genetic testing
  • Genomics
  • GLP-1s
  • Government
  • Guarantees
  • Health and Human Services
  • Health systems
  • Heart medications
  • History
  • Humalog
  • Humira
  • Idacio
  • Inflation
  • Kurt Harden
  • Lawsuits
  • Legislation
  • Limited Use HRA
  • Lobbying
  • Luke Burchard
  • MDMA (ecstasy)
  • MedBen
  • MedBen Access
  • MedBen Basics
  • MedBen Board of Directors\
  • MedBen employees
  • MedBen Rx
  • MedBen Rx Advocate
  • MedBen Rx Alliance
  • MedBen Rx News
  • MedBen University
  • Medicare
  • Mobile app
  • Mounjaro
  • News
  • Nutrigenomics
  • Online Services
  • Opinions
  • Outcomes
  • Overprescribing
  • Own Use
  • Ozempic
  • Patient advocacy program
  • Perigon Pharmacy 360
  • Pharmacies
  • Pharmacogenomics
  • Pharmacy Benefits Manager (PBM)
  • Pharmacy Services Administrator (PSA)
  • Precision medicine
  • Prescription drugs
  • Prescription Portal
  • Pricing solutions
  • Psychedelic drugs
  • Rebates
  • Regulatory
  • Reporting
  • Research
  • Rx Advertising
  • Rx Costs
  • Rx Facts
  • Rx prices
  • Rx Spending
  • RxDC report
  • Savings
  • Specialty Drugs
  • Spread Pricing
  • State legislation
  • Statins
  • Stelara
  • Study
  • Surveys
  • Transparency
  • Trend
  • TruDataRx
  • Trulicity
  • Value
  • Ventegra
  • Wegovy
  • Weight loss
  • Weight loss drugs
  • Weight management
  • Wellness
  • White paper
  • Zepbound
  • About Us
  • Contact Us
  • Blog
  • Online Services
  • MedBen Access
  • Sitemap
  • Privacy
  • MedBen.com

Sign Up for our Newsletter

  • This field is for validation purposes and should be left unchanged.
© 2025 MedBen Rx. All rights reserved.